Financials
Financial year 2025
Geneeskunde voor het Volk - Zelzate from Zelzate, company number BE0420570026, closed financial year 2025 with a result of € -152,792 after tax. For that financial year Geneeskunde voor het Volk - Zelzate recorded a gross margin of € 2.1 million and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 260,055 to € -152,792. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 21, 2026.
€ 1.1 million
▼ 13% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -152,792
▼ still € 260,055 profit in 2024
Profit after tax over the fiscal year.
€ 1.2 million
▲ 24% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
23.1
▲ 3.8 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 1.8 million
€ 77,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 8,698
▲ 5% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 196,600
▲ 5% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,960,824 | € 1,706,094 | € 2,075,652 | € 2,052,721 | ▼ 1% |
| Profit after taxes | € 298,839 | € -100,970 | € 260,055 | € -152,792 | ▼ € 412,847 |
| Equity | € 1,050,348 | € 949,378 | € 1,209,433 | € 1,056,640 | ▼ 13% |
| Total debts | € 299,095 | € 273,638 | € 306,143 | € 197,350 | ▼ 36% |
| Cash | € 1,290,894 | € 652,175 | € 942,074 | € 1,167,957 | ▲ 24% |
| Land & buildings | € 25,928 | € 23,986 | € 19,200 | € 14,414 | ▼ 25% |
| Retained profit | € 938,383 | € 837,413 | € 1,097,468 | € 944,675 | ▼ 14% |
| Balance sheet total | € 1,349,443 | € 1,223,016 | € 1,515,576 | € 1,253,990 | ▼ 17% |
| Employees (FTE) | 23.1 | 23.5 | 19.3 | 23.1 | ▲ 3.8 |
Key figures of Geneeskunde voor het Volk - Zelzate, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Geneeskunde voor het Volk - Zelzate?
What happened at Geneeskunde voor het Volk - Zelzate in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 152,792 (▼ € 412,847 vs 2024). Source: NBB ↗
- Niki Blondeel became a director. NBB
- Rita Verspreet became a director. NBB
- Brecht Bruynsteen became a director. NBB
- Karel Van Bever became a director. NBB
- New establishment in Zelzate. KBO
- Start of the company according to the CBE. KBO
In short
From € 298,839 profit in 2022 to € 152,792 loss in 2025.
Best year ever: 2022, with € 298,839 profit.
On average € 88,900 of value added per employee in 2025.
A new publication or filing at Geneeskunde voor het Volk - Zelzate? We notify you, reason included.
Follow Geneeskunde voor het Volk - ZelzateDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Geneeskunde voor het Volk - Zelzate are Niki Blondeel, Rita Verspreet, Brecht Bruynsteen and Karel Van Bever.
Directors
According to the 2025 annual accounts
Niki Blondeel
Director
since 2022
Rita Verspreet
Director
since 2012
Brecht Bruynsteen
Director
since 2012
Karel Van Bever
Chairman of the board
since 2012
Establishments
Establishment units
Physical locations of this company
Hoogbouwplein 6
9060 Zelzate
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0420.570.026
- VAT number
- BE 0420.570.026
- Registered office
- Hoogbouwplein 6, 9060 Zelzate
- Names & denominations
- Geneeskunde voor het Volk - Zelzate · GHVH Zelzate
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 1 March 1980
- Peppol
- Active · Active since 8 Sept 2026
- Activities · NACE
Activiteiten van huisartspraktijken
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Beroepsopleiding
Promotie en organisatie van scheppende en uitvoerende kunstevenementen